Ledipasvir and sofosbuvir and Pantoprazole Injection
Determining the interaction of Ledipasvir and sofosbuvir and Pantoprazole Injection and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Depending on the dose, pantoprazole may interfere with the absorption of ledipasvir and reduce its effectiveness. Talk to your doctor or pharmacist if you have any questions or concerns. You may need a dose adjustment of pantoprazole to safely use both medications. You should take pantoprazole simultaneously with the dose of ledipasvir on an empty stomach. Contact your doctor if your symptoms worsen or your condition changes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:ADJUST DOSE: Coadministration of ledipasvir with proton pump inhibitors may reduce its gastrointestinal absorption. Ledipasvir exhibits pH-dependent solubility, with increased solubility at lower pH. In 17 healthy volunteers, mean ledipasvir peak plasma concentration (Cmax) and systemic exposure (AUC) decreased by 48% and 42%, respectively, when a single 30 mg dose of ledipasvir was administered 2 hours after omeprazole given at a dosage of 20 mg once daily. When a single 90 mg-400 mg dose of ledipasvir-sofosbuvir was administered simultaneously with omeprazole 20 mg once daily, mean ledipasvir Cmax decreased by 11% and AUC decreased by just 4%.
MANAGEMENT: Proton-pump inhibitors at doses comparable to omeprazole 20 mg or lower should only be administered either simultaneously with or up to 2 hours after ledipasvir-sofosbuvir under fasted conditions. Some authorities advise against administering proton pump inhibitors before ledipasvir-containing products; however, a timeframe of dosage separation has not been specified.
- "Product Information. Harvoni (ledipasvir-sofosbuvir)." Gilead Sciences, Foster City, CA.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
Generic Name: ledipasvir / sofosbuvir
Brand name: Harvoni
Synonyms: Ledipasvir and Sofosbuvir
Generic Name: pantoprazole
Brand name: Protonix, Protonix IV
Synonyms: Pantoprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ledipasvir and sofosbuvir-Pantoprazole Intravenous
- Ledipasvir and sofosbuvir-Pantoprazole Sodium
- Ledipasvir and sofosbuvir-Panzyga (Immune Globulin (Human)-ifas (IV))
- Ledipasvir and sofosbuvir-Panzyga (Immune Globulin Injection (IV))
- Ledipasvir and sofosbuvir-Panzyga Intravenous
- Ledipasvir and sofosbuvir-Papacon
- Pantoprazole Injection-Ledipasvir and Sofosbuvir Tablets
- Pantoprazole Injection-Leena
- Pantoprazole Injection-Lefamulin
- Pantoprazole Injection-Lefamulin Acetate
- Pantoprazole Injection-Lefamulin Injection
- Pantoprazole Injection-Lefamulin Tablets